$WOR
WORTHINGTON ENTERPRISES, INC.

2014 Q4 Form 10-Q Financial Statement

#000119312515006521 Filed on January 09, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2013 Q4 2013 Q3
Revenue $871.0M $769.9M $692.3M
YoY Change 13.13% 23.65% 3.94%
Cost Of Revenue $745.8M $641.7M $581.3M
YoY Change 16.23% 21.58% 1.56%
Gross Profit $125.2M $128.2M $111.0M
YoY Change -2.35% 35.19% 18.49%
Gross Profit Margin 14.38% 16.66% 16.03%
Selling, General & Admin $77.31M $78.40M $71.54M
YoY Change -1.39% 20.42% 20.39%
% of Gross Profit 61.74% 61.14% 64.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.20M $20.10M $19.46M
YoY Change 5.5% 24.81% 29.85%
% of Gross Profit 16.93% 15.67% 17.54%
Operating Expenses $77.31M $78.40M $71.54M
YoY Change -1.39% 20.42% 20.39%
Operating Profit $33.19M $19.50M $38.64M
YoY Change 70.22% -32.35% 15.62%
Interest Expense $9.676M $6.258M $6.240M
YoY Change 54.62% -1.2% 18.65%
% of Operating Profit 29.15% 32.09% 16.15%
Other Income/Expense, Net $1.200M $2.500M $10.90M
YoY Change -52.0% 733.33% 5350.0%
Pretax Income $47.06M $36.80M $70.29M
YoY Change 27.87% -23.35% 37.9%
Income Tax $15.60M $8.459M $13.93M
% Of Pretax Income 33.15% 22.99% 19.82%
Net Earnings $29.46M $22.98M $54.56M
YoY Change 28.22% -27.8% 60.64%
Net Earnings / Revenue 3.38% 2.98% 7.88%
Basic Earnings Per Share $0.44 $0.33 $0.78
Diluted Earnings Per Share $0.43 $0.32 $0.76
COMMON SHARES
Basic Shares Outstanding 67.11M shares 69.30M shares 69.60M shares
Diluted Shares Outstanding 69.18M shares 71.83M shares 72.08M shares

Balance Sheet

Concept 2014 Q4 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.50M $109.1M $121.0M
YoY Change -11.55% 231.61% 296.72%
Cash & Equivalents $96.54M $109.1M $121.0M
Short-Term Investments
Other Short-Term Assets $98.00M $69.70M $73.90M
YoY Change 40.6% 11.88% 3.94%
Inventory $454.8M $392.4M $376.7M
Prepaid Expenses
Receivables $491.4M $430.8M $436.2M
Other Receivables $13.70M $2.600M $2.400M
Total Short-Term Assets $1.154B $1.005B $1.010B
YoY Change 14.91% 26.35% 19.39%
LONG-TERM ASSETS
Property, Plant & Equipment $501.9M $505.0M $503.9M
YoY Change -0.61% 9.77% 14.29%
Goodwill $283.4M $212.6M $213.6M
YoY Change 33.3% 18.23% 36.3%
Intangibles $150.5M $128.0M $163.4M
YoY Change 17.58% 11.51% 65.52%
Long-Term Investments $194.7M $174.5M $184.4M
YoY Change 11.54% -30.83% -24.43%
Other Assets $22.45M $16.58M $17.49M
YoY Change 35.37% -11.07% -7.47%
Total Long-Term Assets $1.153B $1.037B $1.083B
YoY Change 11.21% 1.08% -1.98%
TOTAL ASSETS
Total Short-Term Assets $1.154B $1.005B $1.010B
Total Long-Term Assets $1.153B $1.037B $1.083B
Total Assets $2.307B $2.041B $2.093B
YoY Change 13.03% 12.11% 7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $324.9M $283.0M $311.2M
YoY Change 14.79% 29.25% 30.82%
Accrued Expenses $60.96M $42.47M $38.72M
YoY Change 43.53% 23.3% 0.23%
Deferred Revenue
YoY Change
Short-Term Debt $10.77M $43.45M $62.19M
YoY Change -75.22% -1.2% 21.38%
Long-Term Debt Due $101.1M $1.107M $1.099M
YoY Change 9036.4% -6.42% -12.5%
Total Short-Term Liabilities $578.1M $451.5M $504.3M
YoY Change 28.06% 24.43% 28.41%
LONG-TERM LIABILITIES
Long-Term Debt $573.7M $405.7M $405.9M
YoY Change 41.43% -0.28% -0.28%
Other Long-Term Liabilities $62.30M $69.63M $65.08M
YoY Change -10.53% -4.61% -6.19%
Total Long-Term Liabilities $636.0M $475.3M $471.0M
YoY Change 33.82% -0.94% -1.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $578.1M $451.5M $504.3M
Total Long-Term Liabilities $636.0M $475.3M $471.0M
Total Liabilities $1.336B $1.060B $1.123B
YoY Change 26.07% 6.18% 10.81%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $872.5M $863.8M $857.6M
YoY Change
Total Liabilities & Shareholders Equity $2.307B $2.041B $2.093B
YoY Change 13.03% 12.11% 15.93%

Cashflow Statement

Concept 2014 Q4 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income $29.46M $22.98M $54.56M
YoY Change 28.22% -27.8% 60.64%
Depreciation, Depletion And Amortization $21.20M $20.10M $19.46M
YoY Change 5.5% 24.81% 29.85%
Cash From Operating Activities $1.400M $29.32M $94.46M
YoY Change -95.22% -66.83% 33.05%
INVESTING ACTIVITIES
Capital Expenditures $23.27M $17.06M $13.35M
YoY Change 36.42% 115.65% -20.06%
Acquisitions $14.54M -$276.0K -$52.96M
YoY Change -5369.2% -100.44%
Other Investing Activities -$15.80M $20.00M $66.20M
YoY Change -179.0% -137.74% 903.03%
Cash From Investing Activities -$39.00M $2.970M $52.81M
YoY Change -1413.13% -104.87% -621.79%
FINANCING ACTIVITIES
Cash Dividend Paid $12.14M $10.41M
YoY Change 16.63% 16.23%
Common Stock Issuance & Retirement, Net $20.98M $15.51M $28.32M
YoY Change 35.25% 225.04% 160.85%
Debt Paid & Issued, Net $511.0K $285.0K $284.0K
YoY Change 79.3% -21.49% -35.75%
Cash From Financing Activities -12.70M -44.28M -77.61M
YoY Change -71.32% 76.83% 8.65%
NET CHANGE
Cash From Operating Activities 1.400M 29.32M 94.46M
Cash From Investing Activities -39.00M 2.970M 52.81M
Cash From Financing Activities -12.70M -44.28M -77.61M
Net Change In Cash -50.30M -11.99M 69.66M
YoY Change 319.38% -598.09% -760.51%
FREE CASH FLOW
Cash From Operating Activities $1.400M $29.32M $94.46M
Capital Expenditures $23.27M $17.06M $13.35M
Free Cash Flow -$21.87M $12.26M $81.11M
YoY Change -278.42% -84.77% 49.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68029037 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121049000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146921000
CY2014Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
218801000
CY2014Q4 us-gaap Equity Method Investments
EquityMethodInvestments
194686000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19749000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
324886000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
101140000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
62629000
CY2014Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
674874000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60961000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109055000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
971008000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
628464000
CY2014Q4 us-gaap Senior Notes
SeniorNotes
100000000
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
3073000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
578147000
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4396000
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2753000
CY2014Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
10303000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
822495000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
872502000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62297000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
573734000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2307391000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45500000
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
6324000
CY2014Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
711589000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
156959000
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
10769000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
98506000
CY2014Q4 us-gaap Liabilities
Liabilities
1336383000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
360127000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62985000
CY2014Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
413268000
CY2014Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
13010000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2997000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96537000
CY2014Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
43115000
CY2014Q4 us-gaap Goodwill
Goodwill
283418000
CY2014Q4 us-gaap Land
Land
15238000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
501909000
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
491687000
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
337000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
822495000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46310000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
853219000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22450000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1154394000
CY2014Q4 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
25571000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
99853000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1130373000
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
337000
CY2014Q4 us-gaap Assets
Assets
2307391000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
23064000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
290261000
CY2014Q4 us-gaap Inventory Net
InventoryNet
454775000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
236126000
CY2014Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
28264000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
13757000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
150534000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
118796000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
266107000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Receivable From Partner
EquityMethodInvestmentSummarizedFinancialInformationReceivableFromPartner
8635000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Short Term Borrowings
EquityMethodInvestmentSummarizedFinancialInformationShortTermBorrowings
16178000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
4460000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
18664000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
53333000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Other Current Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
470266000
CY2014Q4 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
59576000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51385000
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
944882000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
611271000
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
7029000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
589663000
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4953000
CY2014Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
4879000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
814132000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3581000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
333744000
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
101173000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
71333000
CY2014Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
655963000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49873000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
850812000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76426000
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
554790000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2296381000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35506000
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4475000
CY2014Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
674488000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
128595000
CY2014Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
10362000
CY2014Q2 us-gaap Minority Interest
MinorityInterest
94070000
CY2014Q2 us-gaap Liabilities
Liabilities
1351499000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Equity Or Capital
EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital
351468000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
78514000
CY2014Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
11044000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3043000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190079000
CY2014Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
32135000
CY2014Q2 us-gaap Goodwill
Goodwill
251093000
CY2014Q2 us-gaap Land
Land
15260000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498861000
CY2014Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
493127000
CY2014Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
1284000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
814132000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43769000
CY2014Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
213848000
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
179113000
CY2014Q2 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
32074000
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
90957000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1110132000
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1284000
CY2014Q2 us-gaap Assets
Assets
2296381000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
24272000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
294001000
CY2014Q2 us-gaap Inventory Net
InventoryNet
410002000
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
213173000
CY2014Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
32235000
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5438000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
145993000
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
848889000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22399000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
1198922000
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
105872000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebt
268350000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Receivable From Partner
EquityMethodInvestmentSummarizedFinancialInformationReceivableFromPartner
12717000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Short Term Borrowings
EquityMethodInvestmentSummarizedFinancialInformationShortTermBorrowings
40992000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Long Term Debt Current Maturities
EquityMethodInvestmentSummarizedFinancialInformationLongTermDebtCurrentMaturities
4510000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Other Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherNoncurrentLiabilities
20217000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Cash
EquityMethodInvestmentSummarizedFinancialInformationCash
52997000
CY2014Q2 wor Equity Method Investment Summarized Financial Information Other Current Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherCurrentAssets
454417000
CY2014Q2 wor Distributions In Excess Of Investment In Unconsolidated Affiliates
DistributionsInExcessOfInvestmentInUnconsolidatedAffiliates
59287000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2635000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
123783000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69138000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72089000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
197 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69454000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2551000
us-gaap Gross Profit
GrossProfit
239196000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
277000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
569000
us-gaap Payments Of Dividends
PaymentsOfDividends
10407000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2638000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
5481000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6255000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-15229000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5832000
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
165882000
us-gaap Sales Revenue Net
SalesRevenueNet
1462191000
us-gaap Profit Loss
ProfitLoss
84693000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
8032000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1707000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-575000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21323000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107085000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-53233000
us-gaap Operating Income Loss
OperatingIncomeLoss
58137000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
84490000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50316000
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
11000000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
11850000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
780717000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
2233000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30414000
us-gaap Net Income Loss
NetIncomeLoss
77534000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-3248000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13409000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
3704000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
2551000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
48037000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
9421000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
105783000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
90948000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8502000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
35375000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-21534000
us-gaap Interest Expense
InterestExpense
12498000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
9223000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
149935000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5832000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-296000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
57670000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22392000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
1777000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1222995000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
39555000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-121888000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-70277000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6487000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
55775000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
23733000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1777000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16700000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7159000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6458000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2703000
wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
-5179000
wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
4456000
wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
19441000
wor Estimated Annual Effective Tax Rate For Continuing Operations
EstimatedAnnualEffectiveTaxRateForContinuingOperations
0.278 pure
wor Joint Venture Transactions
JointVentureTransactions
928000
wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
116072000
wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
5892000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
588000
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
WORTHINGTON INDUSTRIES INC
dei Trading Symbol
TradingSymbol
WOR
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2443000 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Economic (Non-designated) Hedges</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 4%" align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">We enter into foreign currency contracts to manage our foreign exchange exposure related to inter-company and financing transactions that do not meet the requirements for hedge accounting treatment. We also enter into certain commodity contracts that do not qualify for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings.</font></p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
55894000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66912000 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-11-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69780000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Entity Central Index Key
EntityCentralIndexKey
0000108516
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
113744 shares
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2014-12-17
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67337000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
454000
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
240000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16862000
us-gaap Gross Profit
GrossProfit
254730000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-2374000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
813000
us-gaap Payments Of Dividends
PaymentsOfDividends
22250000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
2867000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-1430000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17782000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5836000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5753000
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
164945000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
14227000
us-gaap Unusual Or Infrequent Item Gain Gross
UnusualOrInfrequentItemGainGross
846000
us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
11721000
us-gaap Sales Revenue Net
SalesRevenueNet
1733426000
us-gaap Profit Loss
ProfitLoss
80275000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-18292000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8104000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3216000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35130000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
117988000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
51093000
us-gaap Payments For Restructuring
PaymentsForRestructuring
4784000
us-gaap Operating Income Loss
OperatingIncomeLoss
85394000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57462000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
41620000
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-20115000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
460000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
781262000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-4878000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47146000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
4082000
us-gaap Net Income Loss
NetIncomeLoss
73630000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-3437000
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-2118000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16628000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
7300000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1543000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-920000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-16862000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
50243000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
7803000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
103930000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
62493000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8853000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16185000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6027000
us-gaap Interest Expense
InterestExpense
19192000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
-3671000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
152563000
us-gaap Unusual Or Infrequent Item Loss Gross
UnusualOrInfrequentItemLossGross
243000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
42569000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5753000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-93542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37713000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-510000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1478696000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
41567000
us-gaap Dividends Cash
DividendsCash
24553000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-41412000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
359000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-454000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-108024000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1186000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-510000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-3437000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30205000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4677000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6645000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5031000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6496000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20480000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
41620000
wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
398000
wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
4335000
wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
18105000
wor Estimated Annual Effective Tax Rate For Continuing Operations
EstimatedAnnualEffectiveTaxRateForContinuingOperations
0.335 pure
wor Impact To Fair Value Of Derivative Assets And Liabilities As Result Of Recognition On Net Basis
ImpactToFairValueOfDerivativeAssetsAndLiabilitiesAsResultOfRecognitionOnNetBasis
324000
wor Joint Venture Transactions
JointVentureTransactions
190000
wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
113343000
wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
5552000
wor Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred Tax
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferredTax
1251000
CY2014 wor Impact To Fair Value Of Derivative Assets And Liabilities As Result Of Recognition On Net Basis
ImpactToFairValueOfDerivativeAssetsAndLiabilitiesAsResultOfRecognitionOnNetBasis
730000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2522000 shares
CY2013Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
29319000
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69138000 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71826000 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
396 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69304000 shares
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3037000
CY2013Q4 us-gaap Gross Profit
GrossProfit
128232000
CY2013Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-394000
CY2013Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
285000
CY2013Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
10407000
CY2013Q4 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
875000
CY2013Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
661000
CY2013Q4 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
3506000
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
46149000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
31730000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4722000
CY2013Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
30734000
CY2013Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13110000
CY2013Q4 us-gaap Interest Expense
InterestExpense
6258000
CY2013Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-139000
CY2013Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21838000
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3390000
CY2013Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7574000
CY2013Q4 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1534000
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
76068000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
769900000
CY2013Q4 us-gaap Profit Loss
ProfitLoss
28340000
CY2013Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
3698000
CY2013Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4072000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36799000
CY2013Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-276000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19499000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26051000
CY2013Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19800000
CY2013Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
7188000
CY2013Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
357236000
CY2013Q4 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-1228000
CY2013Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17060000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
22977000
CY2013Q4 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1869000
CY2013Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2472000
CY2013Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
353000
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
3037000
CY2013Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21086000
CY2013Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3668000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78395000
CY2013Q4 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1534000
CY2013Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
185000
CY2013Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11994000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8459000
CY2013Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
308000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
641668000
CY2013Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20095000
CY2013Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-44283000
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2013Q4 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-18736000
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4286000
CY2013Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2970000
CY2013Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
16086000
CY2013Q4 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
308000
CY2013Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23922000
CY2013Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5363000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5679000
CY2013Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4556000
CY2013Q4 wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
-1182000
CY2013Q4 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
2233000
CY2013Q4 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
9104000
CY2013Q4 wor Joint Venture Transactions
JointVentureTransactions
786000
CY2013Q4 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
51532000
CY2013Q4 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
2862000
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2014Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2076000 shares
CY2014Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1409000
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66912000 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69181000 shares
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
147859 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67105000 shares
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7270000
CY2014Q4 us-gaap Gross Profit
GrossProfit
125223000
CY2014Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-2578000
CY2014Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
511000
CY2014Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
12138000
CY2014Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-2973000
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9151000
CY2014Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6916000
CY2014Q4 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
621000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
76193000
CY2014Q4 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
1089000
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
871012000
CY2014Q4 us-gaap Profit Loss
ProfitLoss
31455000
CY2014Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-10243000
CY2014Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5232000
CY2014Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3095000
CY2014Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16087000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47055000
CY2014Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14543000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
33192000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20745000
CY2014Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21549000
CY2014Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2370000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
388712000
CY2014Q4 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-4465000
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23273000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
29462000
CY2014Q4 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-1493000
CY2014Q4 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2300000
CY2014Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1220000
CY2014Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1881000
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-7270000
CY2014Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22319000
CY2014Q4 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
813000
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
44490000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22304000
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4498000
CY2014Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14235000
CY2014Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5492000
CY2014Q4 us-gaap Interest Expense
InterestExpense
9676000
CY2014Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
129000
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77308000
CY2014Q4 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
621000
CY2014Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
143000
CY2014Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-50384000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15600000
CY2014Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-1092000
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
745789000
CY2014Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21200000
CY2014Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-12727000
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2014Q4 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-196000
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
566000
CY2014Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39066000
CY2014Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
921000
CY2014Q4 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1092000
CY2014Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-72095000
CY2014Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1993000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1559000
CY2014Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-505000
CY2014Q4 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20480000
CY2014Q4 wor Restructuring And Other Expense Income
RestructuringAndOtherExpenseIncome
405000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Interest Expense
EquityMethodInvestmentSummarizedFinancialInformationInterestExpense
2173000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Depreciation And Amortization
EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization
8983000
CY2014Q4 wor Joint Venture Transactions
JointVentureTransactions
83000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Operating Income Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingIncomeLoss
49864000
CY2014Q4 wor Equity Method Investment Summarized Financial Information Income Tax Expense Benefit
EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpenseBenefit
2799000

Files In Submission

Name View Source Status
0001193125-15-006521-index-headers.html Edgar Link pending
0001193125-15-006521-index.html Edgar Link pending
0001193125-15-006521.txt Edgar Link pending
0001193125-15-006521-xbrl.zip Edgar Link pending
d833854d10q.htm Edgar Link pending
d833854dex311.htm Edgar Link pending
d833854dex312.htm Edgar Link pending
d833854dex321.htm Edgar Link pending
d833854dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g833854fs_logo.jpg Edgar Link pending
g833854g17y85.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wor-20141130.xml Edgar Link completed
wor-20141130.xsd Edgar Link pending
wor-20141130_cal.xml Edgar Link unprocessable
wor-20141130_def.xml Edgar Link unprocessable
wor-20141130_lab.xml Edgar Link unprocessable
wor-20141130_pre.xml Edgar Link unprocessable